These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 2906344)

  • 21. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
    Skouby SO
    Int J Fertil; 1987; 32 Suppl():45-8. PubMed ID: 2906346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
    Kloosterboer HJ; Rekers H
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):370-3. PubMed ID: 2142577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of modern low-dose oral contraceptives on hemostasis.
    Daume E
    Adv Contracept; 1990 Dec; 6 Suppl():51-67; discussion 68. PubMed ID: 2149806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
    Omsjø IH; Oian P; Maltau JM; Osterud B
    Acta Obstet Gynecol Scand; 1989; 68(1):27-30. PubMed ID: 2508417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic changes during treatment with two different progestogens.
    Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
    Massafra C; Capitani S; Bernabei A; Scillone L
    Rev Fr Gynecol Obstet; 1988 Apr; 83(4):251-5. PubMed ID: 2969134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation effects of oral contraception.
    Bonnar J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and metabolic effects of gestodene and levonorgestrel.
    Rabe T; Runnebaum B; Kohlmeier M; Harenberg J; Weicker H
    Int J Fertil; 1987; 32 Suppl():29-44. PubMed ID: 2906345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
    Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestodene or norgestimate: an open, randomized, parallel-group study.
    Winkler UH; Oberhoff C; Bier U; Schindler AE; Gillain D
    Int J Fertil Menopausal Stud; 1995; 40(5):260-8. PubMed ID: 8556031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
    Rechberger T; Tomaszewski J; Pieprzowska-Białek A; Kulik-Rechberger B; Skorupski P
    Contraception; 2004 Jun; 69(6):477-80. PubMed ID: 15157792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
    Prasad RN; Koh S; Ratnam SS
    Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostasis profile in women taking low-dose oral contraceptives.
    David JL; Gaspard UJ; Gillain D; Raskinet R; Lepot MR
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):420-3. PubMed ID: 2142579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gestodene Study Group.
    Bruni V; Croxatto H; De La Cruz J; Dhont M; Durlot F; Fernandes MT; Andrade RP; Weisberg E; Rhoa M
    Gynecol Endocrinol; 2000 Apr; 14(2):90-8. PubMed ID: 10836195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progestagen-dependent effect on some plasma proteins during oral contraception.
    Liukko P; Erkkola R; Bergink EW
    Gynecol Obstet Invest; 1988; 25(2):118-22. PubMed ID: 2967233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic aspects of the new low-dose oral contraceptives.
    Chez RA
    Int J Fertil; 1989 Sep; 34 Suppl():50-4. PubMed ID: 2576259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological and endocrine profiles of gestodene.
    Spona J; Huber J
    Int J Fertil; 1987; 32 Suppl():6-14. PubMed ID: 2906347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.